HDL cholesterol blood test
HDL cholesterol. Also called: HDL-C, High-density lipoprotein cholesterol, "Good" cholesterol
HDL cholesterol is the cholesterol carried in high-density lipoprotein. Low HDL (below 40 mg/dL) goes with higher heart risk, but raising HDL with drugs has not prevented heart attacks, and very high HDL is not protective either.
One of the four values on a standard Lipid Panel. The panel page also covers the advanced tests, ApoB and Lp(a).
At a glance
| What it measures | The cholesterol carried in high-density lipoprotein (HDL). |
|---|---|
| Sample | Serum or plasma. Fasting does not change HDL. |
| Adult cut-offs | Low below 40 mg/dL; high 60 or higher (ATP III). Quest's adult limits: 40 or higher for men, 50 or higher for women. |
| Peptides that move it | Raised modestly by Tirzepatide and Semaglutide; reported improved on Tesamorelin. |
| Lab code | LOINC 2085-9 (Labcorp 001925, Quest 608) |
What is HDL cholesterol?
HDL cholesterol is the cholesterol inside high-density lipoprotein particles. In the Framingham Study it was the strongest lipid predictor of heart disease at older ages, with an inverse link: the lower the HDL, the higher the risk. That link is a marker of risk rather than a cause: raising HDL with drugs or through genes has not lowered heart-attack risk.
How it is made and regulated
Where it is made
HDL levels rise with regular exercise, moderate alcohol and oral estrogen, and fall with obesity, cigarette smoking and diabetes, according to Quest's test notes. ATP III also notes that regular physical activity raises HDL.
What controls it
Genes matter too. Carriers of an endothelial lipase variant (LIPG 396Ser) had HDL about 0.14 mmol/L higher than non-carriers, but no lower risk of heart attack. Drugs including progestins, anabolic steroids and corticosteroids lower HDL.
How it travels in the blood
HDL cholesterol is measured in serum or plasma; Labcorp uses an enzymatic method and Quest spectrophotometry. Both run it alone or as part of the lipid panel.
How long it lasts
HDL is stable from hour to hour: fasting or a recent meal does not change it, according to the European consensus on non-fasting lipids. Changes come over weeks to months with weight, exercise or drugs.
What it does
Low HDL predicts heart disease, but very high HDL is not protective. In 52,268 men and 64,240 women from two Copenhagen studies, the link between HDL and death was U-shaped, with the lowest mortality at about 73 mg/dL in men and 93 mg/dL in women. Torcetrapib raised HDL by 72.1% but increased deaths.
Reference ranges
Higher HDL is usually better up to a point. Labcorp flags anything at 39 mg/dL or below; Quest uses 40 or higher for men and 50 or higher for women; ATP III calls below 40 low and 60 or higher high.
Labcorp (test 303756)
| Group | Range (mg/dL) |
|---|---|
| Adults (sample reports for women aged 31 and 64) | >39 |
An HDL of 39 mg/dL is flagged low on Labcorp's sample report.
Quest Diagnostics (test 608)
| Group | Range (mg/dL) |
|---|---|
| Men, 20 years and older | 40 or higher |
| Women, 20 years and older | 50 or higher |
Children and teens
| Group | Range (mg/dL) |
|---|---|
| Under 20 years | >45 |
Read from Quest's test directory for the East service area.
NCEP Adult Treatment Panel III (NHLBI)
| Group | Range (mg/dL) |
|---|---|
| Low | <40 |
| High | 60 or higher |
| Metabolic syndrome criterion, men | <40 |
| Metabolic syndrome criterion, women | <50 |
ATP III Table 2 and Table 8.
Quest and the ATP III metabolic-syndrome criteria use a higher low-HDL line for women (50 mg/dL) than for men (40 mg/dL).
Units: Labs outside the US report HDL in mmol/L. Divide mg/dL by 38.6 to convert: 40 mg/dL is about 1.0 mmol/L. [7]
Is there an "optimal" range?
Higher HDL is linked with lower risk, but only up to a point, and raising it with drugs has not helped.
60 mg/dL or higher is high (protective)
60 or higher
NCEP ATP III
Classifies 60 mg/dL or higher as high HDL.
Very high HDL is not better
Lowest mortality about 73 mg/dL (men) and 93 mg/dL (women)
Copenhagen cohorts (Madsen 2017)
Both extreme high and low HDL were linked with higher all-cause mortality.
Sources: [9]
What raises it
| Factor | How | How much |
|---|---|---|
| Regular exerciseLifestyle | Quest and ATP III both note HDL rises with regular physical activity. | No published magnitude [5] [6] |
| Moderate alcohol, oral estrogenLifestyle | Listed by Quest as raising HDL. | No published magnitude [5] |
| NiacinMedication | Extended-release niacin raises HDL, without lowering cardiovascular events in AIM-HIGH. | Median 35 to 42 mg/dL at 2 years [13] |
| Weight loss on Tirzepatide or SemaglutidePeptide | HDL rose in their obesity trials. | +8.0% vs -0.7% on placebo (tirzepatide 15 mg) [8] [14] |
What lowers it
| Factor | How | How much |
|---|---|---|
| Obesity, cigarette smoking, diabetesCondition | Listed by Quest as lowering HDL. | No published magnitude [5] |
| Progestins, anabolic steroids, corticosteroidsMedication | ATP III lists these as drugs that lower HDL. | No published magnitude [6] |
| DanazolMedication | In the goserelin label's comparison, danazol cut HDL sharply. | -21.3 mg/dL over 6 months [15] |
Peptides that affect HDL cholesterol
How each peptide in our library changes HDL cholesterol, from FDA label tables and trials. No study has measured HDL cholesterol after dosing CJC-1295, Ipamorelin, HGH Fragment 176-191 or AOD-9604; a PubMed search for each peptide with cholesterol, triglycerides or lipids finds no human data (the only AOD-9604 lipid paper is a mouse study of fat loss, not blood lipids).
| Peptide | Effect on HDL cholesterol | Size of effect | Evidence |
|---|---|---|---|
| Tesamorelin | Raises | No figure in the abstract: in a 26-week randomized trial in people with HIV and abdominal fat, the authors report that HDL cholesterol "improved significantly" on tesamorelin; the open sources give no sizeThe direction is reported; the size is not available in an open source. [16] | Human trials |
| MK-677 (Ibutamoren) | Unclear | Obese men: HDL rose at 2 weeks of MK-677 and the LDL/HDL ratio was lower at 8 weeks. Older adults (2 years): no difference between groups in HDLA short-term rise in one trial, none in the longer one. [17] [18] | Human trials |
| Liraglutide | Raises | Saxenda 3 mg (Study 1, adults without diabetes): HDL +2.3% vs +0.5% on placebo; relative difference +1.9%A very small rise. [19] | FDA label |
| Semaglutide | Raises | Wegovy 2.4 mg, 68 weeks (adults with obesity or overweight): HDL +5.2% vs +1.4% on placebo; relative difference +3.8%A small HDL rise with weight loss. [14] | FDA label |
| Tirzepatide | Raises | Zepbound 15 mg, 72 weeks (Study 1): HDL +8.0% vs -0.7% on placebo; relative difference +8.7%The largest HDL change among the drugs listed here. [8] | FDA label |
| Goserelin | Unclear | Women treated for endometriosis, 6 months: HDL +2.7 mg/dL on goserelin vs -21.3 mg/dL on danazol; there was no placebo groupLittle change in HDL, which held up much better than on danazol. [15] | FDA label |
What high or low results can mean
A high result
60 mg/dL or higher is high in ATP III. Moderately high HDL goes with lower heart risk, but extremely high HDL was linked with higher mortality in large cohorts.
- Regular exercise
- Moderate alcohol
- Oral estrogen
- Genetic variants
A low result
Below 40 mg/dL is low (ATP III) and counts toward metabolic syndrome (below 40 in men, below 50 in women). It marks higher heart risk.
- Obesity and inactivity
- Cigarette smoking
- Diabetes
- High triglycerides
- Drugs such as anabolic steroids
How the test works
| Sample | Serum (preferred) or plasma, 1 mL at Labcorp. |
|---|---|
| Fasting | HDL is not affected by fasting. Quest asks for a 9-12 hour fast only when HDL is ordered with triglycerides outside a lipid panel. The European Atherosclerosis Society and EFLM recommend routine non-fasting lipid profiles: after normal meals, the largest average changes are +26 mg/dL for triglycerides and -8 mg/dL for total and LDL cholesterol, while HDL does not change. They suggest a fasting sample when non-fasting triglycerides are above 440 mg/dL. |
| Timing | ATP III recommends a lipid profile every 5 years from age 20; if the sample is non-fasting and HDL is below 40 mg/dL, it asks for a follow-up profile. |
| Lab differences | Enzymatic assay at Labcorp; spectrophotometry at Quest. |
| Retesting | Compare results from the same lab; changes from exercise or weight loss take weeks to months. |
| Labcorp order code | 001925: High-density Lipoprotein Cholesterol (HDL-C) |
| Labcorp order code | 303756: Lipid Panel |
| Quest Diagnostics order code | 608: HDL Cholesterol |
| Quest Diagnostics order code | 7600: Lipid Panel, Standard |
| LOINC codes |
|
History
HDL rose to fame as the "good" cholesterol, then fell from its pedestal as a treatment target.
- 1977The Framingham Study reports HDL as the strongest lipid predictor of heart disease at older ages, with an inverse association. [1]
- 2001NCEP ATP III raises the low-HDL cut-off from below 35 to below 40 mg/dL. [6] [12]
- 2007Torcetrapib raises HDL by 72.1% but increases cardiovascular events and deaths. [2]
- 2011AIM-HIGH stops early: niacin added to statins raises HDL but does not reduce cardiovascular events. [13]
- 2012A Mendelian randomisation study finds genetically higher HDL does not lower heart-attack risk. [3]
- 2017Copenhagen cohorts show a U-shaped link between HDL and all-cause mortality. [9]
FAQ
What is a good HDL level?
ATP III calls below 40 mg/dL low and 60 or higher high. Quest's adult limits are 40 or higher for men and 50 or higher for women.
What is a normal HDL for a 40-year-old man?
Quest's range for men 20 and older is 40 mg/dL or higher; Labcorp flags 39 or lower as low. ATP III calls below 40 low and 60 or higher high.
Is the HDL cut-off different for women?
Yes. Quest's adult limit and the ATP III metabolic-syndrome criterion are 50 mg/dL for women and 40 for men.
Is higher HDL always better?
No. In large Copenhagen cohorts the lowest mortality was at about 73 mg/dL in men and 93 mg/dL in women; extremely high HDL was linked with higher mortality.
Sources: [9]
Should I try to raise my HDL with drugs?
Drug-raised HDL has not prevented heart attacks: torcetrapib raised HDL by 72.1% but increased deaths; niacin raised median HDL from 35 to 42 mg/dL with no fewer events (16.4% vs 16.2%); and people with genetically higher HDL had no lower heart-attack risk.
Does fasting affect HDL?
No. The European consensus found HDL is not affected by fasting or a recent meal.
Sources: [7]
What raises HDL naturally?
Regular exercise, moderate alcohol and oral estrogen raise it; obesity, smoking and diabetes lower it, according to Quest's test notes.
Do GLP-1 drugs raise HDL?
A little. In obesity trials HDL rose 8.0% on Tirzepatide 15 mg (vs a 0.7% fall on placebo), 5.2% on Semaglutide 2.4 mg and 2.3% on Liraglutide 3 mg.
Does tesamorelin raise HDL?
The 26-week trial in people with HIV reported that HDL "improved significantly" on Tesamorelin, but the open sources do not give the size of the change.
Sources: [16]
References
- Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62(5):707-14. PMID 193398
- Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007;357(21):2109-22. PMID 17984165
- Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012;380(9841):572-80. PMID 22607825
- Labcorp. Test 001925: High-density Lipoprotein Cholesterol (HDL-C). Methodology, specimen and LOINC map. labcorp.com/tests/001925/high-density-lipoprotein-cholesterol-hdl-c
- Quest Diagnostics. Test 608: HDL Cholesterol. Test directory: methodology, patient preparation, age- and sex-specific reference range and clinical significance. testdirectory.questdiagnostics.com/test/test-detail/608/hdl-cholesterol?cc=PHP
- National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary. NIH Publication No. 01-3670. National Heart, Lung, and Blood Institute; 2001. Table 2 (LDL, total and HDL cholesterol classification), triglyceride classification and Table 8 (metabolic syndrome). nhlbi.nih.gov/files/docs/guidelines/atp3xsum.pdf
- Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-58. PMID 27122601
- Zepbound (tirzepatide) injection. FDA prescribing information, Table 3 (cardiometabolic parameters, Studies 1 and 2). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017;38(32):2478-2486. PMID 28419274
- Labcorp. Sample report, test 303756 (Lipid Panel): reference intervals as printed for a 31-year-old woman (reported 06/10/2024). files.labcorp.com/testmenu-d8/sample_reports/303756.pdf
- Labcorp. Sample report, test 235010 (Lipid Panel With LDL/HDL Ratio): reference intervals as printed for a 64-year-old woman (reported 06/10/2024). files.labcorp.com/testmenu-d8/sample_reports/235010.pdf
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. PMID 11368702
- AIM-HIGH Investigators, Boden WE, Probstfield JL, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365(24):2255-67. PMID 22085343
- Wegovy (semaglutide) injection 2.4 mg. FDA prescribing information, Table 10 (cardiometabolic parameters, Study 2). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Zoladex (goserelin implant) 3.6 mg. FDA prescribing information: lipid changes in women treated for endometriosis. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=294b168b-6e5f-4db9-bf70-d599271458b3
- Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-70. PMID 18057338
- Svensson J, Jansson JO, Ottosson M, et al. Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a). J Clin Endocrinol Metab. 1999;84(6):2028-33. PMID 10372705
- Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008;149(9):601-11. PMID 18981485
- Saxenda (liraglutide) injection 3 mg. FDA prescribing information, Table 6 (cardiometabolic parameters, Study 1). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
Educational information, not medical advice. Lab ranges and test codes were checked on October 31, 2026. Always use the range printed on your own report, and talk to a clinician about your results.